Nuclear receptors control gene transcription by binding to speci c promoter regions of DNA in the presence of ligand. Orphan nuclear receptors are nuclear receptors for which the endogenou s ligand(s) has yet to be identi ed. Systematic evaluation of orphan nuclear receptors can elucidate species differences in xenobiotic metabolism in addition to aiding in identi cation of endogenou s ligands. The receptor-binding af nity and speci city of various chemicals, with subsequen t determination of the genes controlled by nuclear receptors, are goals of investigations into orpha n nuclear receptor structure/function and can provide valuable tools in predicting drug interactions and toxicity.
INTRODUCTION
Nuclear receptors are receptors that bind to DNA as monom ers, hom odimers, or heterodimers and, in conjunction with a variety of cofactors, affect gene transcription. The nuclear receptor (NR) gene family contains approximately 50 members in humans ( Figure 1 ). The biologic effects of NR are far-reaching and often profoun d since their signal is often greatly ampli ed downstream, even in the presence of extremely small amounts of activating ligands. Therefore, interaction with nuclear receptors by endogenous or exogenous ligands can have an array of consequences on the m etabolism or excretion of toxicants, drugs, and endogenous horm ones (10) . The following is a general summ ary of a more detailed seminar presented at the 19th Annual Symposium of the Society of Toxicologic Pathologists.
NUCLEAR RECEPTOR STRUCTURE AND FUNCTION NR contain 2 major regions that largely dictate receptor function: the ligand-and DNA -binding domains (LBD and DBD, respectively) ( Figure 1 ). The LBD and DBD of NR determine the speci city and activity of the ligand-induced response (10) . The pattern of gene expression regulated by a nuclear receptor is also dictated by the sequence of the region of DNA to which it binds. These sequences are called the DNA response elements (DRE) or xenobiotic response elements (XRE). Since the genes encoding m any drug-metabolizing enzym es contain DRE/XRE, the analysis of NR -regulated gene expression can aid in prediction of drug interactions and toxicity (6, 8, 11, 13) . In this regard, it is important to Address correspond ence to: Richard Thomas Miller, Glaxo Wellcome, R&D 9.3012, Five Moore Drive, Research Triangle Park, North Carolina 27709 . note that some fam ilies of NR are notoriously indiscrete with respect to their ability to be activated by m any types of synthetic drug molecules, a characteristic often referred to as receptor prom iscuity (9) . G enerally, there is a high degree of sequence identity of NR across m am m alian species, particularly in the D BD and LBD . H ow ever, even sm all differences in sequence can have a profound im pact on binding and response (20) . These species differences m ay lead to m arked differences in toxicologic and m orphologic responses to xenobiotics. The receptor for the peroxisom e proliferator class of rodent hepatocarcinogens, called peroxisom e proliferator-activated receptor alpha (PPA R ), exem pli es m any of the species differences in N R structure/function that can be obser ved between rodents and hum ans. Until the endogenous fatty acid and eicosanoid ligands were recently identi ed, PPA R w as considered an orphan nuclear receptor (2) . Species differences in response to PPA R agonists have been attributed to 1 or m ore of the follow ing speci c receptor activation attributes: differences in sequence of D RE in key PPA R -regulated genes, differences in the expression level of hepatic PPA R (ie, relatively high abundance in rodents com pared to hum ans), and the presence of PPA R splice variants in hum ans (1, 2, 12, 18) . The differences between hum an and rodent hepatic PPA R and its dow nstream effectors have been used to explain the lack of peroxisom e proliferation that is seen in hum ans and to evaluate the relative hepatocarcinogenic risk to PPA R agonists across species (1, 7) .
ORPHAN NUCLEAR RECEPTORS
Orphan NR are NR for which an endogenous ligand has yet to be identi ed. Research into orphan NR has added greatly to our understanding of NR function and activity in addition to increasing our appreciation of the diverse roles of these receptors in mammalian physiology (10) (Figure 1) . One of the recently characterized orphan NR is the pregnane X receptor (PXR) (9, 11, 16) . This receptor shows only moderate sequence identity in its LBD across the mammalian species characterized so far ( Figure 2) . PXR binds to XRE in the promoter region of the cytochrome P -450 m ono-oxygenase 3A4 (cyp3a4) (9, 13) . This P -450 is one of the major drug-metabolizing enzym es in the liver and intestine, and its expression is colocalized with PXR ( Figure 3 ). Interestingly, CYP3A expression is up-regulated in response to a broad range of pharmaceutical drugs, leading to a phenomenon of drug-drug interactions (6, 14) . Using binding and functional assays, we have dem onstrated that PXR is the principal regulator of cyp3a gene expression in response to inducers such as rifampicin, pregnenolone 16 carbonitrile, and clotrimazole (9) . Remarkably, the speci city of CYP3A induction parallels the activation pro le of PXR across species. Thus, PXR binding and activation assays will be useful for identifying candidate drugs that are likely to cause drug-drug interactions in hum ans. A striking example of this has been recently reported as a concern for people taking extracts of St. John's wort (3, 4, 5) . Hyperforin, one of the active ingredients in St. John's wort, activates PXR and causes up-regulation of CYP3A4 (Figure 4) (16) . Therefore, St. John's wort m ay have un-desirable consequences when taken in combination with one of the many drugs that are metabolized by CYP3A4. S om e exam ples of d ru gs that are m etabo lized by CYP3A4 include cyclosporin, an immunosuppressant; indinavir, an HIV protease inhibitor; and oral contraceptives (9, 15, 17, 19) .
Constitutive androstane receptor (CA R) is another exam ple of an orphan N R that is likely involved in xenobiotic m etabolism (8, 16) . CA R is expressed in the liver, and activation of CA R by a variety of xenobiotics (eg, phenobarbital) leads to increased expression of cyp2b (8, 16) . Like PXR , variability of xenobiotic-induced activation of CAR across species m ay be a reection of differences in the sequence identity of the LBD and has obvious im plications for evaluating rodent-to-hum an tissue response and thus hum an safety assessm ent. SUMMARY NR encom pass a large and ever expanding group of receptors that contains, among others, receptors that regulate expression of xenobiotic m etabolizing enzymes en-coded by the cyp mono-oxy genase gene fam ily. There are a num ber of m ono-oxygenases for which the m echanism of induction has yet to be elucidated. Further analysis of orphan NR may yield clues as to how other members of the CYP superfamily are induced on exposure to xenobiotics.
